2016 - 2019 Prognostic model to support their decision making of cancer patients in the era of precision medicine
Show all
Papers (57):
Masayoshi Ishihara, Keisuke Fukui, Tetsuji Tonda. Flexible Detection of Birth Cohort Effects on Cancer Mortality. Smart Innovation, Systems and Technologies. 2025. 273-283
Ayana Okazaki, Shogo Matsuda, Takuya Kotani, Keisuke Fukui, Takaho Gon, Ryu Watanabe, Atsushi Manabe, Mikihito Shoji, Keiichiro Kadoba, Ryosuke Hiwa, et al. Identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis: multicenter REVEAL cohort study. Frontiers in Immunology. 2025. 15
Katsunori Matsueda, Seiji Kawano, Keisuke Fukui, Shoichiro Hirata, Takuya Satomi, Shoko Inoo, Kenta Hamada, Yoshiyasu Kono, Masaya Iwamuro, Yoshiro Kawahara, et al. Long-term outcomes of endoscopic resection of superficial esophageal squamous cell carcinoma in late-elderly patients. Journal of gastroenterology and hepatology. 2024
Hirokazu Yanagihara, Isamu Nagai, Keisuke Fukui, Yuta Hijikawa. Ridge parameter optimization using a modified Cp statistic in multivariate generalized ridge regression for the GMANOVA model. Procedia Computer Science. 2023. 225. 1651-1660
Hadrien Charvat, Keisuke Fukui, Tomohiro Matsuda, Kota Katanoda, Yuri Ito. Impact of cancer and other causes of death on mortality of cancer patients: A study based on Japanese population-based registry data. International journal of cancer. 2023. 153. 6. 1162-1171
伊藤 ゆり, 堀 芽久美, 福井 敬祐, 太田 将仁, 中田 佳世, 杉山 裕美, 伊藤 秀美, 大木 いずみ, 西野 善一, 宮代 勲, et al. がんサバイバーの死亡リスクはいつ一般集団と同等になるのか?条件付き5年生存率が100%以上となるタイミング(When is cancer survivors' risk of death the same as the general population? timing of 100%+conditional 5-year survival). 日本癌学会総会記事. 2022. 81回. E-3035
Yuri Ito, Keisuke Fukui, Naoki Kondo, Kota Katanoda, Tomoki Nakaya, Tomotaka Sobue. Trends in area-level socioeconomic inequalities of lung cancer mortality by age group in Japan: 1995-2014. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2021. 50. 112-112